Quarterly update to PFE drug pipeline: www.pfizer.com/files/research/pipeline/2011_0228/pipeline_2011_0228.pdf www.pfizer.com/research/product_pipeline/product_pipeline.jspInteresting in that I don't see the partnership with RIGL for R343 targeting asthma that was in Phase 2 either in the current pipeline or the list of discontinued projects.